Bentham Science Logo

Contents

Current Cancer Therapy Reviews, Volume 2 - Number 3

Biological Basis of Novel Therapies for Myelodysplastic Syndrome

, 2(3): 199 - 209

Eyal C. Attar and Karen K. Ballen


DOI: 10.2174/157339406777934708




Current Treatment of Relapsed Ovarian Carcinoma

, 2(3): 211 - 221

Aristotle Bamias, Alexandros Rodolakis and Meletios A. Dimopoulos


DOI: 10.2174/157339406777934726




Lenalidomide: Cancer Therapy via Antiangiogenesis and Immunomodulation

, 2(3): 223 - 229

Tanyifor M. Tohny, Jurgen Venitz, Alex Sparreboom and William D. Figg


DOI: 10.2174/157339406777934690




A Role for Tumor Suppressor Protein p53 in the Fidelity of DNA Synthesis and Resistance Towards Nucleoside Analogs

, 2(3): 231 - 241

Mary Bakhanashvili and Galia Rahav


DOI: 10.2174/157339406777934672




Molecular Profiles of Sentinel and Non-Sentinel Lymph Nodes in Breast Cancer Progression and Prognosis

, 2(3): 243 - 253

Gajanan V. Sherbet


DOI: 10.2174/157339406777934735




Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells

, 2(3): 255 - 270

Caryl J. Giuliano, Sarah J. Freemantle and Michael J. Spinella


DOI: 10.2174/157339406777934681




Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy

, 2(3): 271 - 279

Yong Wang, Virginia Probin and Daohong Zhou


DOI: 10.2174/157339406777934717




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science